Anzeige
Mehr »
Donnerstag, 05.06.2025 - Börsentäglich über 12.000 News
Neuer Top-Geologe an Bord - zündet jetzt die nächste Kursrakete?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N7AA | ISIN: CA58504D1006 | Ticker-Symbol: MLZ
Frankfurt
04.06.25 | 08:04
0,045 Euro
+0,90 % +0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDIPHARM LABS CORP Chart 1 Jahr
5-Tage-Chart
MEDIPHARM LABS CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0420,05104.06.
0,0440,04904.06.

Aktuelle News zur MEDIPHARM LABS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoMedipharm Labs Corp: Medipharm director nominees garner ISS recommendation7
FrMedipharm Labs Corp: Medipharm calls dissident Apollo's allegations baseless6
29.05.MediPharm Labs Corp.: MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder419TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE:MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids...
► Artikel lesen
29.05.Buzz on the Bullboards: Bombardier vs Boeing, MediPharm "under attack"21
28.05.MediPharm Labs Corp.: MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan168TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today issued a Letter...
► Artikel lesen
27.05.Apollo Capital calls for MediPharm board overhaul3
26.05.Medipharm Labs Corp: Medipharm begins pot inhaler production for int'l sales8
MEDIPHARM LABS Aktie jetzt für 0€ handeln
26.05.Stocks in Play: MediPharm Labs Corp.1
26.05.What is going on with MediPharm Labs?1
26.05.MediPharm Labs Corp.: MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement191TORONTO, May 26, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based...
► Artikel lesen
23.05.Medipharm Labs Corp: Medipharm urges holders to oppose dissident nominees7
23.05.MediPharm Labs Corp.: MediPharm Labs Cautions Shareholders about Dissident Nominees' Governance Failures at Check-Cap Ltd.200TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm", the "Company", or "we"), a pharmaceutical company specialized in precision-based cannabinoids, today provided...
► Artikel lesen
23.05.Apollo Capital stellt MediPharm Labs-Vorstand vor Aktionärsversammlung in Frage3
23.05.Apollo Capital challenges MediPharm Labs board ahead of shareholder meeting1
22.05.Medipharm Labs Corp: Medipharm to close facility sale to Rubicon in June3
22.05.MediPharm Labs Corp.: MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June181TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce...
► Artikel lesen
22.05.Medipharm Labs Corp: Medipharm warns of McGee in multiple litigation filings3
21.05.MediPharm Labs Corp.: MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings144TORONTO, May 21, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today alerted its shareholders...
► Artikel lesen
21.05.Medipharm Labs Corp: Medipharm dissident Apollo files amended circular4
20.05.Apollo Capital seeks overhaul at MediPharm Labs8
Seite:  Weiter >>
66 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1